Genzyme Corp (NASDAQ:GENZ.DL)
| CAPS Rating |
|
|---|
GENZ.DL
VS S&P 500 (SPY)
GENZ.DL News and Commentary
- 10K filing by OSIR shows it can help Japan with Radiation exposure treatment. – Blog at The Motley Fool
- Protalix BioTherapeutics Inc sends out a profit taking signal – Blog at The Motley Fool
- Extra Cellular Matrix – Blog at The Motley Fool
- 15 Big Players In Biotechnology Industry – Blog at The Motley Fool
- The Daily Long and Short Setup – Blog at The Motley Fool
- Carl Icahn’s Current Investment Portfolio As Of September 2010 – Blog at The Motley Fool
- Carl Icahn’s Current Investment Portfolio – Blog at The Motley Fool
- Genoptix, Inc. - A Vampire Stock – Blog at The Motley Fool
- Buying call options – Blog at The Motley Fool
This ticker is not currently Ratable.
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
Powered by: CAPSAll Players
0
Outperform
0
Underperform
All-Star Players
0
Outperform
0
Underperform
Wall Street
0
Outperform
0
Underperform
RSS Headlines
Fool UK
